No Picture
News

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China

SAN DIEGO, Feb. 23, 2023 /PRNewswire/ — Today, Invivoscribe announced that its Shanghai lab in China has received CAP accreditation. Now the entire Invivoscribe testing lab network serving the US, the EU, Japan, and China […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Capstan Therapeutics to Participate in Cowen 43rd Annual Health Care Conference

SAN DIEGO & PHILADELPHIA–(BUSINESS WIRE)–Capstan Therapeutics, Inc., a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted lipid nanoparticles, today announced that Capstan President and Chief Executive Officer, Laura Shawver, Ph.D., will […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Lineage Enters Into Option and License Agreement With Eterna Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies to replace and restore specific cell types of the human body, today announced that […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally

SAN DIEGO–(BUSINESS WIRE)– #Dexcom–Dexcom Showcases Accuracy, Simplicity and Connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

SAN DIEGO, Feb. 21, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that the […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

WUHAN, China and SAN DIEGO, Feb. 21, 2023 /PRNewswire/ — Neurophth Therapeutics, Inc. (“Neurophth”) announced today that the last patient has been enrolled in the Phase III clinical trial for the treatment of Leber hereditary […]

No Picture
News

Fentanyl Is Widening Grip on the Nation as Western Presence and Detection with Other Drugs Increase to Record Highs, Millennium Health Signals Report™ Shows

SAN DIEGO–(BUSINESS WIRE)–Detection of fentanyl in urine drug test (UDT) specimens remains near historic highs and fentanyl co-detection in individuals using heroin, prescription opioids, methamphetamine, or cocaine has reached new heights, according to the Millennium […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ionis announces new donidalorsen data and presentations at the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting

Phase 2 open-label study data reinforce donidalorsen’s potential to be a best-in-class prophylactic treatment for patients living with hereditary angioedema Ionis is preparing to launch donidalorsen, one of its three near-term commercial opportunities CARLSBAD, Calif., […]

No Picture
News

FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum

TORONTO–(BUSINESS WIRE)—- $HUGE #FSDPharma–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of […]

ADVERTISEMENT — Advertise With Biotech Networks